These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38641321)

  • 1. Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?
    Trégouët DA; Morange PE
    J Thromb Haemost; 2024 Jul; 22(7):1826-1834. PubMed ID: 38641321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies.
    Trégouët DA; Morange PE
    Br J Haematol; 2018 Feb; 180(3):335-345. PubMed ID: 29082522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to the analysis of next generation sequencing data and its application to venous thromboembolism.
    Cunha ML; Meijers JC; Middeldorp S
    Thromb Haemost; 2015 Nov; 114(5):920-32. PubMed ID: 26446408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACMG clinical laboratory standards for next-generation sequencing.
    Rehm HL; Bale SJ; Bayrak-Toydemir P; Berg JS; Brown KK; Deignan JL; Friez MJ; Funke BH; Hegde MR; Lyon E;
    Genet Med; 2013 Sep; 15(9):733-47. PubMed ID: 23887774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and annotation of whole-genome or whole-exome sequencing-derived variants for clinical diagnosis.
    Worthey EA
    Curr Protoc Hum Genet; 2013 Oct; 79():9.24.1-9.24.24. PubMed ID: 24510652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing applications in cancer research.
    Zhang W; Nykter M; Chen K
    Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening and functional exploration of prothrombin Arg596 related mutations in Chinese venous thromboembolism patients.
    Wu X; Li L; Ding Q; Wang X; Wu F; Wu W
    J Clin Pathol; 2018 Jul; 71(7):614-619. PubMed ID: 29331940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous Thromboembolism Research Priorities: A Scientific Statement From the American Heart Association and the International Society on Thrombosis and Haemostasis.
    Cushman M; Barnes GD; Creager MA; Diaz JA; Henke PK; Machlus KR; Nieman MT; Wolberg AS;
    Circulation; 2020 Aug; 142(6):e85-e94. PubMed ID: 32776842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress and perspective on the applications of whole exome sequencing in venous thromboembolism].
    Zhang Yu Y; Zhai Zhenguo ZG; Wang Chen C
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):974-978. PubMed ID: 30522197
    [No Abstract]   [Full Text] [Related]  

  • 11. Dissecting the genetic determinants of hemostasis and thrombosis.
    Desch KC
    Curr Opin Hematol; 2015 Sep; 22(5):428-36. PubMed ID: 26248003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting rare variants for psychiatric disorders using next generation sequencing: a methods primer.
    Altmann A; Quast C; Weber P
    Curr Psychiatry Rep; 2013 Jan; 15(1):333. PubMed ID: 23250814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.
    Ahmad A; Sundquist K; Palmér K; Svensson PJ; Sundquist J; Memon AA
    J Thromb Thrombolysis; 2019 Feb; 47(2):216-226. PubMed ID: 30368761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation as an intermediate phenotype for venous thrombosis.
    Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
    Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of genetic testing in noncompaction/hypertrabeculation.
    Shieh JT
    Am J Med Genet C Semin Med Genet; 2013 Aug; 163C(3):206-11. PubMed ID: 23843345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncertain thrombophilia markers.
    Franchini M; Martinelli I; Mannucci PM
    Thromb Haemost; 2016 Jan; 115(1):25-30. PubMed ID: 26271270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene and Variant Annotation for Mendelian Disorders in the Era of Advanced Sequencing Technologies.
    Chakravorty S; Hegde M
    Annu Rev Genomics Hum Genet; 2017 Aug; 18():229-256. PubMed ID: 28415856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine.
    Ipe J; Swart M; Burgess KS; Skaar TC
    Clin Transl Sci; 2017 Mar; 10(2):67-77. PubMed ID: 28213901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.